We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Hormel Foods
HRL
$13.8B
| $27.1M | 0.06% |
633,950
+14,798
| +2% | +$638K |
|
302
iShares Core US Aggregate Bond ETF
AGG
$137B
| $26.7M | 0.06% |
250,938
+4,626
| +2% | +$485K |
|
|
TSS
303
DELISTED
Total System Services, Inc.
TSS
| $26.6M | 0.06% |
327,575
-16,906
| -5% | -$1.5M |
|
304
Healthpeak Properties
DOC
$15.1B
| $26.6M | 0.06% |
952,342
+49,412
| +5% | +$1.37M |
|
305
Quest Diagnostics
DGX
$25.7B
| $26.5M | 0.06% |
318,406
-4,082
| -1% | -$383K |
|
306
International Flavors & Fragrances
IFF
$20.2B
| $26.5M | 0.06% |
197,036
+27,130
| +16% | +$3.75M |
|
307
CenterPoint Energy
CNP
$27.7B
| $26.4M | 0.06% |
936,715
+105,348
| +13% | +$2.94M |
|
|
MXIM
308
DELISTED
Maxim Integrated Products
MXIM
| $26.4M | 0.06% |
519,496
+156,697
| +43% | +$8.18M |
|
309
Aptiv
APTV
$12B
| $26.4M | 0.06% |
428,938
-28,213
| -6% | -$2.04M |
|
310
Expeditors International
EXPD
$22B
| $26.3M | 0.06% |
386,769
-20,179
| -5% | -$1.42M |
|
311
iShares Core S&P 500 ETF
IVV
$878B
| $26.3M | 0.06% |
104,354
+69,226
| +197% | +$18.8M |
|
|
K
312
DELISTED
Kellanova
K
| $26.2M | 0.06% |
489,230
+2,680
| +0.6% | +$162K |
|
|
CTXS
313
DELISTED
Citrix Systems Inc
CTXS
| $26.1M | 0.06% |
254,821
-11,500
| -4% | -$1.21M |
|
|
Y
314
DELISTED
Alleghany Corp
Y
| $26.1M | 0.06% |
41,828
+12,300
| +42% | +$7.58M |
|
315
W.W. Grainger
GWW
$65.3B
| $26M | 0.06% |
92,026
-826
| -0.9% | -$246K |
|
316
Freeport-McMoran
FCX
$90B
| $25.9M | 0.06% |
2,513,302
+1,399
| +0.1% | +$16.3K |
|
317
KeyCorp
KEY
$24.2B
| $25.9M | 0.06% |
1,750,125
-18,857
| -1% | -$332K |
|
318
Ulta Beauty
ULTA
$22B
| $25.8M | 0.06% |
105,331
+702
| +0.7% | +$194K |
|
319
DXC Technology
DXC
$1.82B
| $25.5M | 0.06% |
480,320
-9,053
| -2% | -$625K |
|
|
PARA
320
DELISTED
Paramount Global Class B
PARA
| $25.4M | 0.06% |
580,965
-32,326
| -5% | -$1.72M |
|
321
Lumen
LUMN
$6.57B
| $25.4M | 0.06% |
1,674,907
+37,098
| +2% | +$708K |
|
322
NVR
NVR
$16.5B
| $25.2M | 0.05% |
10,339
+2,176
| +27% | +$5.14M |
|
|
WCG
323
DELISTED
Wellcare Health Plans, Inc.
WCG
| $25.1M | 0.05% |
106,258
+4,322
| +4% | +$1.16M |
|
324
KLA
KLAC
$239B
| $25.1M | 0.05% |
2,800,450
-146,760
| -5% | -$1.37M |
|
325
UGI
UGI
$7.74B
| $25M | 0.05% |
468,894
+168,021
| +56% | +$9.34M |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.